Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
28%
OVERLAP
BY WEIGHT
51
# OF OVERLAPPING
HOLDINGS
SBIO
94
HOLDINGS
60%
ALSO IN XBI
XBI
116
HOLDINGS
45%
ALSO IN SBIO
SECTOR DRIFT (SBIO minus XBI)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
CYTOKINETICS INC | 2.6% | 1.6% | 1.6% |
|
AVIDITY BIOSCIENCES INC | 3.2% | 1.4% | 1.4% |
|
RHYTHM PHARMACEUTICALS, INC. | 3.8% | 1.3% | 1.3% |
|
VAXCYTE, INC. | 2.4% | 1.3% | 1.3% |
|
KRYSTAL BIOTECH, INC. | 2.5% | 1.2% | 1.2% |
SBIO Overweight Relative to XBI
|
AXSOME THERAPEUTICS, INC. | 3.4% |
 |
MERUS N.V. | 2.9% |
|
RHYTHM PHARMACEUTICALS, INC. | 2.5% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.3% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | 2.1% |
|
NUVALENT, INC. CLASS A | 2.0% |
|
AVIDITY BIOSCIENCES INC | 1.8% |
|
ACADIA PHARMACEUTICALS INC | 1.7% |
 |
ALKERMES PLC | 1.7% |
|
MIRUM PHARMACEUTICALS, INC. | 1.4% |
SBIO Underweight Relative to XBI
|
ALNYLAM PHARMACEUTICALS INC | -3.5% |
|
INSMED INC | -3.1% |
|
HALOZYME THERAPEUTICS INC | -3.1% |
|
INCYTE CORP | -2.8% |
|
REGENERON PHARMACEUTICALS | -2.6% |
|
UNITED THERAPEUTICS CORP | -2.6% |
|
ABBVIE INC | -2.5% |
|
NEUROCRINE BIOSCIENCES INC | -2.5% |
|
MADRIGAL PHARMACEUTICALS, INC. | -2.4% |
|
GILEAD SCIENCES INC | -2.4% |